28-O-[XYLOPYRANOSYL-(1->3)-XYLOPYRANOSYL-(1->3)-[XYLOPYRANOSYL-(1->4)]-RHAMNOPYRANOSYL-(1->2)-XYLOPYRANOSYL]-ECHINOCYSTIC-ACID-ESTER
Compound with spectra: 1 NMR
![28-O-[XYLOPYRANOSYL-(1->3)-XYLOPYRANOSYL-(1->3)-[XYLOPYRANOSYL-(1->4)]-RHAMNOPYRANOSYL-(1->2)-XYLOPYRANOSYL]-ECHINOCYSTIC-ACID-ESTER](/api/compound/8BPhHmp43Cu.png?ph=true&h=300&w=458 "28-O-[XYLOPYRANOSYL-(1->3)-XYLOPYRANOSYL-(1->3)-[XYLOPYRANOSYL-(1->4)]-RHAMNOPYRANOSYL-(1->2)-XYLOPYRANOSYL]-ECHINOCYSTIC-ACID-ESTER")
| SpectraBase Compound ID | 8BPhHmp43Cu |
|---|---|
| InChI | InChI=1S/C56H90O24/c1-23-41(76-45-37(66)34(63)26(57)19-71-45)43(78-47-39(68)42(29(60)22-73-47)77-46-38(67)35(64)27(58)20-72-46)40(69)48(75-23)79-44-36(65)28(59)21-74-49(44)80-50(70)56-16-15-51(2,3)17-25(56)24-9-10-31-53(6)13-12-32(61)52(4,5)30(53)11-14-54(31,7)55(24,8)18-33(56)62/h9,23,25-49,57-69H,10-22H2,1-8H3/t23-,25?,26+,27+,28+,29+,30?,31?,32-,33+,34-,35-,36-,37+,38+,39+,40+,41-,42-,43-,44+,45-,46-,47-,48-,49-,53-,54+,55+,56+/m0/s1 |
| InChIKey | DWXPFJARKALBCF-BUSMVELSSA-N |
| Mol Weight | 1147.3 g/mol |
| Molecular Formula | C56H90O24 |
| Exact Mass | 1146.582204 g/mol |
| Enantiomer InChIKey | DWXPFJARKALBCF-ATXDJUQVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | C5D5N |
6H,13H-5,13:6,12-Dietheno-5a,12a-(methaniminomethano)-1H,5H,8H,12H-[1,2,4]triazolo[1,2-a][1,2,4]triazolo[1',2':1,2]pyridazino[4,5-d]pyridazine-18-acetic acid, 2,3,9,10-tetrahydro-.alpha.-(2-methylpropyl)-1,3,8,10,17,19-hexaoxo-2,9-diphenyl-, hexyl ester, stereoisomer
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
Diethyl 4,4''-{[(1R,2R)-cyclohexane-1,2-diyl]dinitrilo-3,3,3',3'-tetramethyl-4,4'-[(2",3",7",8"-tetrahydro-2",2",3",3",7",7",8',8'-octamethyl-11"H-dipyrrin-1",9"-diylidene)-dinitrilo]-bis[butanoato](1-)cobalt(III)
41,42,43,44,45,46,47,48-Octamethoxy-4,9,14,19,24,29,34,39-octamethylnonacyclo[35.3.1.1(2,6).1(7,11).1(12,16).1(17,21).1(22,26).1(27,31).1(32,36)]octatetraconta-1(41),2,4,6(48),7,9,11(47),12,14,16(46),17,19,21(45),22,24,26(44),27,29,31(43),32,34,36(42),37,39-tetracosaene
Nickel, (4,4,5,5,9,9,10,10,14,14,15,15,19,19,20,20-hexadecamethyl-21,27-dioxa -2,12,28,29,30,31-hexaazahexacyclo[9.9.7.1(1,18).1(3,6).1(8,11).1(13,16)]hentriaconta-2,6(31),7,12,16(29),17-hexaenato(2-)-N28,N29,N30,N31)-, (SP-4-1)-
(2R,3R,4S,6E,8R,9S,10S,11R,12R,13R)-1-tert-Butyldimethylsilyloxy-2,4,6,8,10,12-hexamethyl-3-(3,4-dimethoxybenzyloxy)-9,11-isopropylidenedioxy-13-(4-methoxybenzyloxy)-12-methoxymethoxypentacec-6-en-5-one
Quamoclin I peracetate [(S)-Convolvulinoic acid 11-O.beta,-D-glucopyranosyl-(1-3)-O-[4-O-2(S)-methylbutyryl-.alpha.,L-rhamnopyranosyl-(1-4)]-O-(2-O-n-dodececanoyl).alpha.,L-rhamnopyranosyl-(1-4)-O-.alpha.-L-rhymnopyranosyl[-(1-2)-.beta.D-fucopyranoside peracetate]
1-(1-(1'-(2",3",6",8"-tetramethyl-4",5"-di(2"-methoxycarbonylethyl)-7"-ethenylporphinyl)ethoxy)ethyl)-3-(1-(1'-(2",4",5",8"-tetramethyl-3"-(1"-hydroxyethyl)-6",7"-di(2"-methoxycarbonylethyl)porphinyl)ethoxy)ethyl)-2,4,5,8-tetramethyl-6,7-di*2-methoxycarbonylethyl)porphine
Quamoclin II peracetate[(S)-Convolvulinoic acid 11-O.beta,-D-glucopyranosyl-(1-3)-O-[4-O-2(S)-methylbutyryl-.alpha.,L-rhamnopyranosyl-(1-4)]-O-(2-O-n-dodececanoyl).alpha.,L-rhamnopyranosyl-(1-4)-O-.alpha.-L-rhymnopyranosyl[-(1-2)-.beta.D-fucopyranoside peracetate]
Iron, di-.mu.-carbonyltetracarbonyl(.eta.5-2,4-cyclopentadien-1-yl)[.mu.-[(2,4,5-.eta.:2,4,5-.eta.)-4,5-diethyl-2,3-dihydro-1,3-dimethyl-1H-1,3- diborol-2-yl-B1,B3:B1,B3]](nickel)-, (Fe-Ni)
| Title | Journal or Book | Year |
|---|---|---|
| Advances in structural elucidation of glucuronide oleanane-type triterpene carboxylic acid 3,28-O-bisdesmosides (1962–1997) | Phytochemistry | 1999 |